Showing results (101-110 of 390) with videos related to
Sort By:
Pageof 39
The Plant Journal : for Cell and Molecular Biology|January 1, 1997
Regulation of flavonol biosynthesis during anther and pistil development, and during pollen tube growth in Solanum tuberosumG J van Eldik, W H Reijnen, R K Ruiter, et al.Oncology|October 16, 2015
Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061Linda Cerbone, Cora N Sternberg, Lisa Sengeløv, et al.Journal of the American College of Cardiology|December 8, 2004
Drug-induced atrial fibrillationCornelis S van der Hooft, Jan Heeringa, Gerard van Herpen, et al.Oral Oncology|August 19, 2019
Health-related quality of life of patients treated with chemoradiotherapy plus or minus prophylactic antibiotics to reduce the number of pneumonias for locally advanced head and neck cancer, the PANTAP studyJanneke C Ham, Carla M L van Herpen, Chantal M L Driessen, et al.British Journal of Cancer|March 25, 2000
Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working PartyC M van Herpen, R L Jansen, W H Kruit, et al.Diabetes|June 25, 2010
Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistanceJoris Hoeks, Noud A van Herpen, Marco Mensink, et al.Plant Molecular Biology|March 1, 1997
Expression of an isoflavone reductase-like gene enhanced by pollen tube growth in pistils of Solanum tuberosumG J van Eldik, R K Ruiter, P H Colla, et al.Science (New York, N.Y.)|September 24, 2005
Genetic engineering of terpenoid metabolism attracts bodyguards to ArabidopsisIris F Kappers, Asaph Aharoni, Teun W J M van Herpen, et al.Acta Oncologica (Stockholm, Sweden)|December 23, 2010
A phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC)Viktor Grünwald, Ingrid M E Desar, John Haanen, et al.Anti-Cancer Drugs|December 1, 2012
Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairmentCarla M L van Herpen, Ulrik Lassen, Ingrid M E Desar, et al.Pageof 39